| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | n/a | n/a |
| Intrinsic value (DCF) | n/a | |
| Graham-Dodd Method | n/a | |
| Graham Formula | 197.06 | 557 |
PSB Industries is a France-based manufacturer specializing in high-quality packaging and specialty chemical products, serving the beauty, spirits, healthcare, and hygiene markets. Founded in 1904 and headquartered in Metz-Tessy, the company produces a diverse range of plastic packaging solutions, including caps, closures, mascaras, lip glosses, jars, and compacts for luxury beauty brands. Additionally, PSB provides medical-grade packaging such as bioabsorbable screws, catheters, orthopedic joints, and blister packs for the healthcare sector. Operating across Europe, the U.S., and Asia, PSB Industries combines innovation with precision manufacturing to meet the stringent demands of its clients. As a key player in the Packaging & Containers industry within the Consumer Cyclical sector, PSB leverages its expertise in surface treatments and technical plastics to maintain a competitive edge in niche markets.
PSB Industries presents a mixed investment profile. While the company operates in specialized packaging segments with high barriers to entry, its FY 2020 financials reveal challenges, including a net loss of €21.6 million and negative diluted EPS of €5.87. However, it generated €15.3 million in operating cash flow and maintains a solid cash position of €88.7 million, which could support recovery efforts. The dividend payout of €45.12 per share suggests a commitment to shareholder returns, but investors should weigh this against the company's debt of €94.5 million and sector-specific risks, such as fluctuating demand in luxury beauty and healthcare packaging. The beta of 1.03 indicates market-aligned volatility, making PSB a potential turnaround play for those bullish on premium packaging demand.
PSB Industries competes in the high-end packaging market by focusing on customization, technical expertise, and premium surface treatments—key differentiators in beauty and healthcare packaging. Its long-standing relationships with luxury brands provide stability, but the company faces pressure from larger global packaging firms with greater economies of scale. PSB’s specialization in bioabsorbable medical components offers a niche advantage, though R&D costs in this segment are high. The company’s geographic footprint in Europe and selective international markets (U.S., Asia) is narrower than multinational rivals, limiting revenue diversification. While its craftsmanship appeals to prestige beauty clients, competition from low-cost Asian manufacturers and sustainability-driven shifts toward alternative materials (e.g., glass, biodegradable plastics) pose structural risks. PSB’s ability to innovate in recyclable plastics and maintain margins amid raw material inflation will be critical to its competitive positioning.